| Disease | muscular dystrophy |
| Comorbidity | C0026848|myopathies |
| Sentences | 1 |
| PubMedID- 22918531 | Inhibition of tgfbeta signaling by losartan treatment greatly improved the phenotype of myopathies associated with laminin-alpha2-deficient congenital muscular dystrophy. |
Page: 1